CN116840472A - Double-colloidal gold test strip for detecting haemonchus contortus and preparation method thereof - Google Patents
Double-colloidal gold test strip for detecting haemonchus contortus and preparation method thereof Download PDFInfo
- Publication number
- CN116840472A CN116840472A CN202310862708.7A CN202310862708A CN116840472A CN 116840472 A CN116840472 A CN 116840472A CN 202310862708 A CN202310862708 A CN 202310862708A CN 116840472 A CN116840472 A CN 116840472A
- Authority
- CN
- China
- Prior art keywords
- protein
- recombinant
- colloidal gold
- nim1
- test strip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 82
- 241000243974 Haemonchus contortus Species 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 116
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 109
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 106
- 239000010931 gold Substances 0.000 claims abstract description 26
- 229910052737 gold Inorganic materials 0.000 claims abstract description 26
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 21
- 239000012528 membrane Substances 0.000 claims abstract description 21
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 21
- 238000003908 quality control method Methods 0.000 claims abstract description 16
- 238000001514 detection method Methods 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 238000002372 labelling Methods 0.000 claims description 11
- 238000005507 spraying Methods 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 4
- 241001529936 Murinae Species 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- 230000009977 dual effect Effects 0.000 claims 1
- 241001494479 Pecora Species 0.000 abstract description 37
- 208000015181 infectious disease Diseases 0.000 abstract description 13
- 238000003745 diagnosis Methods 0.000 abstract description 7
- 238000011161 development Methods 0.000 abstract description 4
- 241000282849 Ruminantia Species 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 54
- 210000002966 serum Anatomy 0.000 description 52
- 241000243976 Haemonchus Species 0.000 description 21
- 241001589086 Bellapiscis medius Species 0.000 description 20
- 238000010586 diagram Methods 0.000 description 19
- 239000000203 mixture Substances 0.000 description 17
- 239000000047 product Substances 0.000 description 16
- 239000006228 supernatant Substances 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 238000012408 PCR amplification Methods 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 230000002550 fecal effect Effects 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000001976 enzyme digestion Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000037029 cross reaction Effects 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 238000010839 reverse transcription Methods 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 101000995861 Arabidopsis thaliana Regulatory protein NPR1 Proteins 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 241000224483 Coccidia Species 0.000 description 3
- 201000003808 Cystic echinococcosis Diseases 0.000 description 3
- 241000244170 Echinococcus granulosus Species 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 101000600885 Homo sapiens Serine/threonine-protein kinase NIM1 Proteins 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 102100037345 Serine/threonine-protein kinase NIM1 Human genes 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 241000242541 Trematoda Species 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000013599 cloning vector Substances 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000672609 Escherichia coli BL21 Species 0.000 description 2
- 241000242711 Fasciola hepatica Species 0.000 description 2
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 101710120037 Toxin CcdB Proteins 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010017866 Gastritis haemorrhagic Diseases 0.000 description 1
- 208000034767 Hypoproteinaemia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283903 Ovis aries Species 0.000 description 1
- 241000935974 Paralichthys dentatus Species 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000005058 diapause Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000003771 laboratory diagnosis Methods 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000011328 necessary treatment Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012772 sequence design Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54391—Immunochromatographic test strips based on vertical flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明提供了一种检测捻转血矛线虫的双重胶体金试纸条及其制备方法。所述双重胶体金试纸条包括:金标垫和硝酸纤维素膜,所述金标垫上标记胶体金溶液标记的重组Hc‑NIM1蛋白和所述胶体金溶液标记的重组Hc‑ES15蛋白,所述硝酸纤维素膜上涂布有抗Hc‑ES15/Hc‑NIM1蛋白抗体包被的C质控线。本发明提供了一种检测捻转血矛线虫的双重胶体金试纸条及其制备方法,该双重胶体金试纸条能够适用于捻转血矛线虫感染的快速、简便和廉价的诊断,这有助于一线基层快速、准确的掌握湖羊捻转血矛线虫病的流行发展,在反刍动物捻转血矛线虫病的防控中具有较好的应用前景。
The invention provides a double colloidal gold test strip for detecting Haemonchus contortus and a preparation method thereof. The double colloidal gold test strip includes: a gold label pad and a nitrocellulose membrane, the gold label pad is marked with recombinant Hc-NIM1 protein labeled by colloidal gold solution and recombinant Hc-ES15 protein labeled by the colloidal gold solution, so The nitrocellulose membrane is coated with C quality control line coated with anti-Hc‑ES15/Hc‑NIM1 protein antibody. The invention provides a double colloidal gold test strip for detecting Haemonchus contortus and a preparation method thereof. The double colloidal gold test strip can be suitable for rapid, simple and cheap diagnosis of Haemonchus contortus infection, which It helps the frontline grassroots to quickly and accurately grasp the epidemic development of Haemonchus contortus in Hu sheep, and has good application prospects in the prevention and control of Haemonchus contortus in ruminants.
Description
技术领域Technical Field
本发明涉及寄生虫检测技术领域,更具体地,涉及检测捻转血矛线虫的双重胶体金试纸条及其制备方法。The invention relates to the technical field of parasite detection, and more specifically to a double colloidal gold test strip for detecting Haemonchus contortus and a preparation method thereof.
背景技术Background Art
捻转血矛线虫在羊体内靠吸食血液为生,可引起患病犊羊、羔羊死亡,给畜牧业带来严重影响。捻转血矛线虫繁殖能力强,对环境有很强的适应能力,能在宿主体内形成滞育虫体抵抗外界威胁,长期存活于宿主体内,引起严重的出血性胃炎、低蛋白血症、贫血和皮下水肿等病症,导致感染羊体重减轻、生产力下降、羊毛产量及品质降低。早发现早治疗可显著降低捻转血矛线虫对羊的危害,因此捻转血矛线虫病的早期诊断尤为重要。Haemonchus twister feeds on blood in sheep and can cause death of sick calves and lambs, bringing serious impacts to animal husbandry. Haemonchus twister has strong reproductive capacity and strong adaptability to the environment. It can form diapause in the host to resist external threats and survive in the host for a long time, causing severe hemorrhagic gastritis, hypoproteinemia, anemia and subcutaneous edema, leading to weight loss, decreased productivity, and reduced wool production and quality in infected sheep. Early detection and early treatment can significantly reduce the harm of Haemonchus twister to sheep, so early diagnosis of Haemonchus twister disease is particularly important.
湖羊感染捻转血矛线虫后,若不采取必要的治疗措施,很可能导致死亡。近年来有研究团队利用血清学和核酸分子学技术建立了ELISA(Enzyme Linked ImmunosorbentAssay,酶联免疫吸附测定)或PCR(Polymerase Chain Reaction,聚酶链式反应)等鉴定方法,大大提升了捻转血矛线虫病诊断的准确性。但这些方法都需要配备专业操作人员,并借助价值不菲的特殊仪器进行操作,且操作过程繁琐,鉴定时间长,成本高。因此,只适用于小规模实验室诊断,而不适用于临床一线基层批量使用,这使得上述两种检测均不能很好的推广应用。由此可见,研制适用于捻转血矛线虫感染的快速、简便和廉价的诊断技术产品,已是刻不容缓。If necessary treatment measures are not taken after Hu sheep are infected with Haemonchus twister, it is likely to lead to death. In recent years, research teams have used serological and nucleic acid molecular techniques to establish identification methods such as ELISA (Enzyme Linked Immunosorbent Assay) or PCR (Polymerase Chain Reaction), which greatly improved the accuracy of diagnosis of Haemonchus twister disease. However, these methods require professional operators and the use of expensive special instruments for operation. The operation process is cumbersome, the identification time is long, and the cost is high. Therefore, it is only suitable for small-scale laboratory diagnosis, but not for batch use at the grassroots level in clinical frontline, which makes the above two tests cannot be well promoted and applied. It can be seen that it is urgent to develop fast, simple and cheap diagnostic technology products suitable for Haemonchus twister infection.
发明内容Summary of the invention
为了解决上述技术问题,本发明提供了一种检测捻转血矛线虫的双重胶体金试纸条及其制备方法,能够适用于捻转血矛线虫感染的快速、简便和廉价的诊断。In order to solve the above technical problems, the present invention provides a double colloidal gold test strip for detecting Haemonchus contortus and a preparation method thereof, which can be applied to the rapid, simple and inexpensive diagnosis of Haemonchus contortus infection.
一方面,本发明实施例提供了一种检测捻转血矛线虫的双重胶体金试纸条,所述双重胶体金试纸条包括:金标垫和硝酸纤维素膜,所述金标垫上标记胶体金溶液标记的重组Hc-NIM1蛋白和所述胶体金溶液标记的重组Hc-ES15蛋白,所述硝酸纤维素膜上涂布有抗Hc-ES15/Hc-NIM1蛋白抗体包被的C质控线。On the one hand, an embodiment of the present invention provides a double colloidal gold test strip for detecting Haemonchus contortus, the double colloidal gold test strip comprising: a gold label pad and a nitrocellulose membrane, the gold label pad being labeled with recombinant Hc-NIM1 protein labeled with colloidal gold solution and recombinant Hc-ES15 protein labeled with the colloidal gold solution, the nitrocellulose membrane being coated with a C quality control line coated with anti-Hc-ES15/Hc-NIM1 protein antibodies.
具体地,所述双重胶体金试纸条还包括样品垫,所述样品垫包括:Na2HPO4·12H2O、KH2PO4、吐温20和去离子水。Specifically, the double colloidal gold test strip further comprises a sample pad, and the sample pad comprises: Na 2 HPO 4 ·12H 2 O, KH 2 PO 4 , Tween 20 and deionized water.
另一方面,本发明实施例提供了一种上述双重胶体金试纸条的制备方法,所述制备方法包括:On the other hand, an embodiment of the present invention provides a method for preparing the above-mentioned double colloidal gold test strip, the preparation method comprising:
制备所述重组Hc-NIM1蛋白和所述重组Hc-ES15蛋白;preparing the recombinant Hc-NIM1 protein and the recombinant Hc-ES15 protein;
利用胶体金溶液标记所述重组Hc-NIM1蛋白,并喷涂在所述金标垫上;Using colloidal gold solution to label the recombinant Hc-NIM1 protein, and spraying it on the gold label pad;
利用所述胶体金溶液标记所述重组Hc-ES15蛋白,并喷涂在所述金标垫上;Using the colloidal gold solution to label the recombinant Hc-ES15 protein, and spraying it on the gold label pad;
将所述重组Hc-NIM1蛋白包被所述T1检测线喷涂于所述硝酸纤维素膜上,将所述重组Hc-ES15蛋白包被所述T2检测线喷涂于所述硝酸纤维素膜上;The recombinant Hc-NIM1 protein is coated on the T1 detection line and sprayed on the nitrocellulose membrane, and the recombinant Hc-ES15 protein is coated on the T2 detection line and sprayed on the nitrocellulose membrane;
将鼠抗重组Hc-ES15蛋白多克隆抗体包被所述C质控线喷涂于所述硝酸纤维素膜上;The mouse anti-recombinant Hc-ES15 protein polyclonal antibody is coated on the C quality control line and sprayed on the nitrocellulose membrane;
制备样品垫;preparing a sample pad;
依次将所述硝酸纤维素膜、所述金标垫、所述样品垫和吸水垫分别粘贴到PVC板上,得到所述双重胶体金试纸条。The nitrocellulose membrane, the gold label pad, the sample pad and the water absorbent pad are sequentially pasted onto a PVC plate to obtain the double colloidal gold test strip.
具体地,标记的所述重组Hc-NIM1蛋白的pH值为6.5。Specifically, the pH value of the labeled recombinant Hc-NIM1 protein is 6.5.
具体地,标记的所述重组Hc-ES15蛋白的pH值为8.5。Specifically, the pH value of the labeled recombinant Hc-ES15 protein is 8.5.
具体地,标记的所述重组Hc-NIM1蛋白的标记量为10μg/mL。Specifically, the labeled amount of the labeled recombinant Hc-NIM1 protein is 10 μg/mL.
具体地,标记的所述重组Hc-ES15蛋白的标记量为6μg/mL。Specifically, the labeled amount of the labeled recombinant Hc-ES15 protein is 6 μg/mL.
具体地,标记的所述重组Hc-NIM1蛋白的浓度为2mg/mL。Specifically, the concentration of the labeled recombinant Hc-NIM1 protein is 2 mg/mL.
具体地,标记的所述重组Hc-ES15蛋白的标记量为2mg/mL。Specifically, the labeled amount of the labeled recombinant Hc-ES15 protein is 2 mg/mL.
具体地,所述鼠抗重组Hc-ES15蛋白多克隆抗体的浓度为2.5mg/mL。Specifically, the concentration of the mouse anti-recombinant Hc-ES15 protein polyclonal antibody is 2.5 mg/mL.
本发明提供了一种检测捻转血矛线虫的双重胶体金试纸条及其制备方法,该双重胶体金试纸条能够适用于捻转血矛线虫感染的快速、简便和廉价的诊断。利用重组Hc-NIM1蛋白和重组Hc-ES15蛋白分别包被的两条检测线,使得本发明实施例提供的双重胶体金试纸条具有良好的敏感性,同时,筛选捻转血矛线虫在L4期和成虫期表达量较高的蛋白作为诊断抗原,在感染后7天至120天均能做出准确诊断,适用于感染期各个阶段的检测。本发明实施例提供的双重胶体金试纸条操作简单,检测快速,有助于一线基层快速、准确的掌握湖羊捻转血矛线虫病的流行发展,在反刍动物捻转血矛线虫病的防控中具有较好的应用前景。The present invention provides a double colloidal gold test strip for detecting Haemonchus twister and a preparation method thereof, and the double colloidal gold test strip can be applied to the rapid, simple and inexpensive diagnosis of Haemonchus twister infection. The double colloidal gold test strip provided by the embodiment of the present invention has good sensitivity by using two detection lines respectively coated with recombinant Hc-NIM1 protein and recombinant Hc-ES15 protein. At the same time, the protein with high expression level of Haemonchus twister in L4 stage and adult stage is screened as a diagnostic antigen, and an accurate diagnosis can be made from 7 days to 120 days after infection, which is suitable for detection at all stages of the infection period. The double colloidal gold test strip provided by the embodiment of the present invention is simple to operate and has fast detection, which helps the front-line grassroots to quickly and accurately grasp the prevalence and development of Haemonchus twister disease in Hu sheep, and has a good application prospect in the prevention and control of Haemonchus twister disease in ruminants.
本发明的其它特征和优点将在随后的说明书中阐述,并且,部分地从说明书中变得显而易见,或者通过实施本发明而了解。本发明的目的和其他优点可通过在说明书、权利要求书以及附图中所特别指出的结构来实现和获得。Other features and advantages of the present invention will be described in the following description, and partly become apparent from the description, or understood by practicing the present invention. The purpose and other advantages of the present invention can be realized and obtained by the structures particularly pointed out in the description, claims and drawings.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
附图用来提供对本发明技术方案的进一步理解,并且构成说明书的一部分,与本申请的实施例一起用于解释本发明的技术方案,并不构成对本发明技术方案的限制。The accompanying drawings are used to provide a further understanding of the technical solution of the present invention and constitute a part of the specification. Together with the embodiments of the present application, they are used to explain the technical solution of the present invention and do not constitute a limitation on the technical solution of the present invention.
图1是本发明实施例一提供的双重胶体金试纸条结构示意图,图中,1为样品垫,2为金标垫,3为硝酸纤维素膜,4为吸水垫,5为PVC板。FIG1 is a schematic diagram of the structure of a double colloidal gold test strip provided in Example 1 of the present invention, in which 1 is a sample pad, 2 is a gold label pad, 3 is a nitrocellulose membrane, 4 is a water-absorbing pad, and 5 is a PVC board.
图2是本发明实施例二提供的大小为474bp的目的条带图。FIG. 2 is a target band diagram of 474 bp in size provided by Example 2 of the present invention.
图3是本发明实施例二提供的大小为390bp的目的条带图。FIG. 3 is a target band diagram of 390 bp in size provided by Example 2 of the present invention.
图4是本发明实施例二提供的Hc-NIM1基因序列比较图。FIG. 4 is a comparison diagram of the Hc-NIM1 gene sequence provided in Example 2 of the present invention.
图5是本发明实施例二提供的Hc-ES15基因序列比较图。FIG. 5 is a comparison diagram of the Hc-ES15 gene sequence provided in Example 2 of the present invention.
图6a是本发明实施例二提供的目的蛋白大小为36kD的表达载体的酶切鉴定图。FIG. 6 a is a diagram showing the enzyme digestion identification of the expression vector of the target protein with a size of 36 kD provided in Example 2 of the present invention.
图6b是本发明实施例二提供的目的蛋白大小为34kD的表达载体的酶切鉴定图。FIG. 6 b is a diagram showing the enzyme digestion identification of the expression vector of the target protein of 34 kD provided in Example 2 of the present invention.
图7a是本发明实施例二提供的L4期羊血清检测到目的条带。FIG. 7 a shows the target band detected by the L4 sheep serum provided in Example 2 of the present invention.
图7b是本发明实施例二提供的成虫期羊血清检测到目的条带。FIG. 7 b shows the target band detected by the adult sheep serum provided in Example 2 of the present invention.
图7c是本发明实施例二提供的阴性对照组检测结果。FIG. 7c is the detection result of the negative control group provided in Example 2 of the present invention.
图8a是本发明实施例二提供的重组Hc-NIM1蛋白的最佳标记pH值。FIG8a is the optimal labeling pH value of the recombinant Hc-NIM1 protein provided in Example 2 of the present invention.
图8b是本发明实施例二提供的重组Hc-ES15蛋白的最佳标记pH值。FIG8b is the optimal labeling pH value of the recombinant Hc-ES15 protein provided in Example 2 of the present invention.
图9a是本发明实施例二提供的重组Hc-NIM1蛋白的最佳标记量。FIG. 9a is the optimal labeling amount of the recombinant Hc-NIM1 protein provided in Example 2 of the present invention.
图9b是本发明实施例二提供的重组Hc-ES15蛋白的最佳标记量。FIG. 9b is the optimal labeling amount of the recombinant Hc-ES15 protein provided in Example 2 of the present invention.
图10是本发明实施例二提供的C质控线包被多抗的最佳浓度。FIG. 10 is an optimal concentration of polyclonal antibody coated on the C quality control line provided in Example 2 of the present invention.
图11a是本发明实施例二提供的T1检测线包被蛋白的浓度为1mg/mL和T2检测线包被蛋白的浓度为1mg/mL。FIG. 11 a shows that the concentration of the protein coated on the T1 detection line provided in Example 2 of the present invention is 1 mg/mL and the concentration of the protein coated on the T2 detection line is 1 mg/mL.
图11b是本发明实施例二提供的T1检测线包被蛋白的浓度为1mg/mL和T2检测线包被蛋白的浓度为2mg/mL。FIG. 11 b shows that the concentration of the protein coated on the T1 detection line provided in Example 2 of the present invention is 1 mg/mL, and the concentration of the protein coated on the T2 detection line is 2 mg/mL.
图11c是本发明实施例二提供的T1检测线包被蛋白的浓度为2mg/mL和T2检测线包被蛋白的浓度为2mg/mL。FIG. 11 c shows that the concentration of the protein coated on the T1 detection line provided in Example 2 of the present invention is 2 mg/mL and the concentration of the protein coated on the T2 detection line is 2 mg/mL.
图12a是本发明实施例二提供的阴性结果判定示意图。FIG. 12a is a schematic diagram of negative result determination provided in Embodiment 2 of the present invention.
图12b是本发明实施例二提供的阳性结果判定示意图。FIG12b is a schematic diagram of positive result determination provided in Embodiment 2 of the present invention.
图12c是本发明实施例二提供的胶体金试纸条失效判定示意图。FIG. 12c is a schematic diagram of determining the failure of a colloidal gold test strip provided in the second embodiment of the present invention.
图13是本发明实施例二提供的交叉反应验证图。FIG. 13 is a cross-reaction verification diagram provided in Example 2 of the present invention.
图14是本发明实施例二提供的胶体金试纸条特异性检测结果图,图中由左至由依次为羊捻转血矛线虫阳性血清、羊捻转血矛线虫阳性血清、羊肝片吸虫阳性血清、羊球虫阳性血清、羊细粒棘球蚴、牛片形吸虫和羊捻转血矛线虫阴性血清。Figure 14 is a graph of the specific detection results of the colloidal gold test strip provided in Example 2 of the present invention, in which from left to right are the positive serum for sheep Haemonchus contortus, the positive serum for sheep Haemonchus contortus, the positive serum for sheep Fasciola hepatica, the positive serum for sheep coccidia, the sheep Echinococcus granulosus, the bovine Fasciola and the negative serum for sheep Haemonchus contortus.
图15是本发明实施例二提供的血清按比例稀释后的检测结果图,图中由左至由依次为血清稀释比例1∶1、1∶5、1∶10、1∶20、1∶40和1∶80以及阴性对照。Figure 15 is a diagram of the test results of serum diluted in proportion provided in Example 2 of the present invention, in which from left to right are serum dilution ratios of 1:1, 1:5, 1:10, 1:20, 1:40 and 1:80 and a negative control.
图16a是本发明实施例二提供的第一次重复试验的检测结果图。FIG. 16 a is a diagram showing the detection results of the first repeated test provided in Example 2 of the present invention.
图16b是本发明实施例二提供的第二次重复试验的检测结果图。FIG. 16 b is a diagram showing the detection results of the second repeated test provided in Example 2 of the present invention.
图16c是本发明实施例二提供的第三次重复试验的检测结果图。FIG. 16c is a diagram showing the detection results of the third repeated test provided in Example 2 of the present invention.
图17a是本发明实施例二提供的保存30天的敏感性检测结果图。FIG. 17 a is a diagram showing the sensitivity test results after 30 days of storage provided in the second embodiment of the present invention.
图17b是本发明实施例二提供的保存60天的敏感性检测结果图。FIG. 17 b is a diagram showing the sensitivity test results after 60 days of storage provided in the second embodiment of the present invention.
图17c是本发明实施例二提供的保存90天的敏感性检测结果图。FIG. 17c is a diagram showing the sensitivity test results after 90 days of storage provided in the second embodiment of the present invention.
图18a是本发明实施例二提供的第5、7、9、11、13和15天的血清检测结果图。Figure 18a is a diagram of the serum test results on days 5, 7, 9, 11, 13 and 15 provided in Example 2 of the present invention.
图18b是本发明实施例二提供的第20、25、30、40、60、90、120和125天的血清检测结果图。Figure 18b is a graph of serum test results on days 20, 25, 30, 40, 60, 90, 120 and 125 provided in Example 2 of the present invention.
具体实施方式DETAILED DESCRIPTION
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例的附图,对本发明实施例的技术方案进行清楚、完整地描述。显然,所描述的实施例是本发明的一部分实施例,而不是全部的实施例。基于所描述的本发明的实施例,本领域普通技术人员在无需创造性劳动的前提下所获得的所有其他实施例,都属于本发明保护的范围。In order to make the purpose, technical solution and advantages of the embodiment of the present invention clearer, the technical solution of the embodiment of the present invention will be clearly and completely described below in conjunction with the drawings of the embodiment of the present invention. Obviously, the described embodiment is a part of the embodiment of the present invention, not all of the embodiments. Based on the described embodiment of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
本实施例所用材料如下:The materials used in this embodiment are as follows:
捻转血矛线虫虫株:由浙江大学的实验室分离、鉴定并保存。Haemonchus contortus strain: isolated, identified and preserved by the laboratory of Zhejiang University.
L4期阳性血清:感染L3期第10天的湖羊血清;成虫阳性血清:感染L3期第30天的湖羊血清;阴性血清:初生未喝过母乳的犊羊血清;羊肝片吸虫阳性血清由扬州大学惠赠,羊球虫阳性血清由内蒙古农业大学惠赠,牛片形吸虫阳性血清、羊细粒棘球蚴阳性血清为本实验室保存。本研究使用的捻转血矛线虫阳性血清均来自同一只湖羊。L4 stage positive serum: serum of Hu sheep infected with L3 stage on the 10th day; adult positive serum: serum of Hu sheep infected with L3 stage on the 30th day; negative serum: serum of newborn calves that have not drunk breast milk; sheep hepatic fluke positive serum was donated by Yangzhou University, sheep coccidia positive serum was donated by Inner Mongolia Agricultural University, and cattle Fasciola positive serum and sheep Echinococcus granulosus positive serum were stored in this laboratory. The positive serum of Haemonchus contortus used in this study was from the same Hu sheep.
实验动物:4只湖羊,年龄:5~6月龄,购于浙江省湖州市咩咩羊场,购买后饲养于浙江大学的动物房内。Experimental animals: 4 Hu sheep, aged 5 to 6 months, purchased from Mie Mie Sheep Farm, Huzhou City, Zhejiang Province, and kept in the animal room of Zhejiang University after purchase.
质粒与菌株:克隆载体pMD19-T Vector(pMD19-T载体)、pET-32a Vector、大肠杆菌TOP 10、大肠杆菌BL 21感受态菌株均购于TaKaRa公司。Plasmids and strains: Cloning vector pMD19-T Vector (pMD19-T vector), pET-32a Vector, Escherichia coli TOP 10, and Escherichia coli BL 21 competent strains were purchased from TaKaRa.
工具酶及试剂:5×HiscriptⅡq-RT Supermix反转录试剂盒(R222-01)(购于南京诺唯赞公司),AceQ Universal SYBR qPCR Master Mix试剂盒(Q511-02)(购于南京诺唯赞公司),质粒提取试剂盒(DR0201050)、凝胶清洁回收试剂盒(DR0101250)(购于浙江易思得生物科技有限公司),LA Taq酶、100bp DNA marker、250bp DNA marker、(购于TaKaRa公司),His-Tag蛋白纯化琼脂填料、蛋白纯化柱外柱、Millipore超滤管、5×SDS、海藻糖、牛血清蛋白BSA(购于上海生工生物工程有限公司),Brand Ford蛋白浓度测定试剂盒(购于上海碧云天生物公司),考马斯亮蓝染液、HRP标记的兔抗小鼠IgG、HRP标记的兔抗绵羊IgG(购于杭州弗德生物科技有限公司),抗His标签鼠源IgG(购于Sigma公司),显色液(购于北京索莱宝公司),蛋白G琼脂糖纯化树脂(购于上海翌圣生物公司),醋酸钠、硫酸铵、氯化钠、碳酸钾、蔗糖(购于国药集团化学试剂有限公司),硝酸纤维素膜(CN140)、玻璃纤维素膜、吸水垫、PVC板、卡壳(购于上海捷宁生物科技有限公司)。Enzymes and reagents: 5×HiscriptⅡq-RT Supermix reverse transcription kit (R222-01) (purchased from Nanjing Novozymes Co., Ltd.), AceQ Universal SYBR qPCR Master Mix kit (Q511-02) (purchased from Nanjing Novozymes Co., Ltd.), plasmid extraction kit (DR0201050), gel cleaning recovery kit (DR0101250) (purchased from Zhejiang Easyside Biotechnology Co., Ltd.), LA Taq enzyme, 100bp DNA marker, 250bp DNA marker, (purchased from TaKaRa Company), His-Tag protein purification agar filler, protein purification column outer column, Millipore ultrafiltration tube, 5×SDS, trehalose, bovine serum albumin BSA (purchased from Shanghai Shenggong Bioengineering Co., Ltd.), Brand Ford protein concentration determination kit (purchased from Shanghai Biyuntian Biotechnology Co., Ltd.), Coomassie brilliant blue dye, HRP-labeled rabbit anti-mouse IgG, HRP-labeled rabbit anti-sheep IgG (purchased from Hangzhou Ford Biotechnology Co., Ltd.), anti-His tag mouse IgG (purchased from Sigma), color development solution (purchased from Beijing Solebow Company), protein G agarose purification resin (purchased from Shanghai Yisheng Biological Company), sodium acetate, ammonium sulfate, sodium chloride, potassium carbonate, sucrose (purchased from Sinopharm Chemical Reagent Co., Ltd.), nitrocellulose membrane (CN140), glass cellulose membrane, absorbent pad, PVC plate, and card shell (purchased from Shanghai Jie Ning Biotechnology Co., Ltd.).
仪器:PCR仪(北京卡尤迪生物科技股份有限公司),智能生化培养箱(宁波江南仪器厂),震荡培养箱(上海知楚仪器有限公司),凝胶成像仪(上海培清科技有限公司),核酸电泳仪(北京六一科技有限公司),蛋白电泳仪(美国Bio-RAD公司),超声波裂解仪(宁波新芝科技有限公司),酶标仪(青岛圣洁仪器系统有限公司),喷金点膜仪(美国伯乐Bio Dot公司)。Instruments: PCR instrument (Beijing Kayoudi Biotechnology Co., Ltd.), intelligent biochemical incubator (Ningbo Jiangnan Instrument Factory), shaking incubator (Shanghai Zhichu Instrument Co., Ltd.), gel imager (Shanghai Peiqing Technology Co., Ltd.), nucleic acid electrophoresis instrument (Beijing Liuyi Technology Co., Ltd.), protein electrophoresis instrument (Bio-RAD, USA), ultrasonic lysator (Ningbo Xinzhi Technology Co., Ltd.), microplate reader (Qingdao Shengjie Instrument System Co., Ltd.), gold dot membrane instrument (Bio Dot, USA).
实施例一Embodiment 1
本实施例提供了一种检测捻转血矛线虫的双重胶体金试纸条,如图1所示,该双重胶体金试纸条包括:金标垫和硝酸纤维素膜,金标垫包括标记有重组Hc-NIM1蛋白和重组Hc-ES15蛋白的胶体金,硝酸纤维素膜包括:由重组Hc-NIM1蛋白包被的T1检测线、重组Hc-ES15蛋白包被的T2检测线和抗Hc-ES15/Hc-NIM1蛋白抗体包被的C质控线。The present embodiment provides a double colloidal gold test strip for detecting Haemonchus contortus, as shown in Figure 1, the double colloidal gold test strip includes: a gold label pad and a nitrocellulose membrane, the gold label pad includes colloidal gold labeled with recombinant Hc-NIM1 protein and recombinant Hc-ES15 protein, the nitrocellulose membrane includes: a T1 detection line coated with recombinant Hc-NIM1 protein, a T2 detection line coated with recombinant Hc-ES15 protein, and a C quality control line coated with anti-Hc-ES15/Hc-NIM1 protein antibodies.
具体地,双重胶体金试纸条还包括:样品垫,样品垫包括:Na2HPO4·12H2O、KH2PO4、吐温20(Tween-20)和去离子水。Specifically, the double colloidal gold test strip further comprises: a sample pad, and the sample pad comprises: Na 2 HPO 4 ·12H 2 O, KH 2 PO 4 , Tween-20 and deionized water.
实施例二Embodiment 2
本实施例提供了一种双重胶体金试纸条的制备方法,该方法包括:This embodiment provides a method for preparing a double colloidal gold test strip, the method comprising:
获得重组Hc-NIM1蛋白和重组Hc-ES15蛋白。Recombinant Hc-NIM1 protein and recombinant Hc-ES15 protein were obtained.
根据GenBank发布的NIM1(登录号:AM040235)基因和ES15(登录号:MT408359)基因的序列分别设计两对特异性的引物,在引物的上下游分别加入BamH I限制性酶切位点和HindⅢ限制性酶切位点。引物序列设计如表1所示。According to the sequences of NIM1 (accession number: AM040235) and ES15 (accession number: MT408359) genes published by GenBank, two pairs of specific primers were designed, and BamH I restriction enzyme site and Hind III restriction enzyme site were added to the upstream and downstream of the primers, respectively. The primer sequence design is shown in Table 1.
表1为引物序列Table 1 shows the primer sequences
按照以下步骤提取捻转血矛线虫的总RNA:取适量捻转血矛线的虫卵、L1期、L2期、L3期、L4期和成虫期样本分别加入6个规格为2mL的离心管中,每个离心管内分别加入1mLTrizol并吹打混匀;向每个离心管中加入5颗直径为3mm的钢珠,将6个离心管分别置于研磨机上,研磨机设置频率为60Hz,研磨时间2min;研磨结束,将每个离心管均置于冰上静置5min;向每个离心管中分别加入200μL氯仿,充分震荡后室温静置10min;于4℃10000g离心15min,得到上清液,将上清液转移至新的离心管中,向新的离心管中加入500μL异丙醇,上下颠倒混匀后,于室温静置10min;配制浓度为75%的乙醇溶液,具体方法为:将250μL DEPC(Diethyl pyrocarbonate,焦碳酸二乙酯)水与750μL无水乙醇混匀;在4℃下10000g离心10min,弃去上清液,得到第一沉淀,向该沉淀中加入1mL浓度为75%的乙醇进行重悬;在4℃下10000g离心5min,弃去上清液,得到第二沉淀,将离心管倒扣于洁净滤纸上直至干燥;向离心管中加入10μL浓度为1%的DEPC水溶解第二沉淀,得到总RNA并放置于-80℃保存。The total RNA of Haemonchus contortus was extracted according to the following steps: appropriate amount of eggs, L1 stage, L2 stage, L3 stage, L4 stage and adult stage samples of Haemonchus contortus were added to 6 centrifuge tubes of 2 mL, 1 mL of Trizol was added to each centrifuge tube and mixed by blowing; 5 steel balls with a diameter of 3 mm were added to each centrifuge tube, and the 6 centrifuge tubes were placed on a grinder respectively, the frequency of the grinder was set to 60 Hz, and the grinding time was 2 min; after grinding, each centrifuge tube was placed on ice for 5 min; 200 μL of chloroform was added to each centrifuge tube, and the mixture was allowed to stand at room temperature for 10 min after being fully shaken; centrifuged at 4°C and 10000 g for 15 min to obtain a supernatant, which was transferred to a new centrifuge tube, 500 μL of isopropanol was added to the new centrifuge tube, and the mixture was mixed by inverting and then allowed to stand at room temperature for 10 min; a 75% ethanol solution was prepared by the following method: 250 μL of DEPC (Diethyl pyrocarbonate, diethyl pyrocarbonate) water was mixed with 750 μL anhydrous ethanol; centrifuged at 10000g for 10 min at 4°C, the supernatant was discarded to obtain a first precipitate, 1 mL of 75% ethanol was added to the precipitate for resuspending; centrifuged at 10000g for 5 min at 4°C, the supernatant was discarded to obtain a second precipitate, and the centrifuge tube was inverted on a clean filter paper until dry; 10 μL of 1% DEPC water was added to the centrifuge tube to dissolve the second precipitate to obtain total RNA and stored at -80°C.
将上述提取的总RNA按照反转录试剂盒的说明书进行反转录操作,反转录体系如表2所示。The total RNA extracted above was reverse transcribed according to the instructions of the reverse transcription kit. The reverse transcription system is shown in Table 2.
将反转录体系混匀后于50℃水浴15min;然后,于85℃水浴5min;最后,在冰上放置5min。得到cDNA,并放置于-80℃保存。After the reverse transcription system is mixed, it is placed in a 50°C water bath for 15 minutes, then in a 85°C water bath for 5 minutes, and finally placed on ice for 5 minutes. The cDNA is obtained and stored at -80°C.
以cDNA作为模板,利用合成的引物NIM1-F和NIM1-R或ES15-F和ES15-R分别与LATaq酶进行PCR扩增,其中,引物NIM1-F和引物NIM1-R一同使用,引物ES15-F和引物ES15-R一同使用,PCR扩增体系如表3所示。Using cDNA as a template, PCR amplification was performed using the synthesized primers NIM1-F and NIM1-R or ES15-F and ES15-R and LATaq enzyme, respectively, wherein primer NIM1-F and primer NIM1-R were used together, and primer ES15-F and primer ES15-R were used together. The PCR amplification system is shown in Table 3.
表3为PCR扩增体系Table 3 shows the PCR amplification system
PCR扩增程序包括:95℃预变性3min;每个循环均包括:94℃变性15s,52℃退火30s,72℃延伸28s,共计34个循环;72℃延伸3min;16℃保持10min。The PCR amplification program included: pre-denaturation at 95°C for 3 min; each cycle included: denaturation at 94°C for 15 s, annealing at 52°C for 30 s, extension at 72°C for 28 s, for a total of 34 cycles; extension at 72°C for 3 min; and holding at 16°C for 10 min.
将PCR扩增产物经浓度为1%的琼脂糖凝胶电泳分析,可见大小为474bp和390bp的目的条带,具体如图2和图3所示。PCR扩增产物按凝胶清洁回收试剂盒说明书进行操作,得到PCR扩增产物。The PCR amplification product was analyzed by 1% agarose gel electrophoresis, and target bands of 474 bp and 390 bp were observed, as shown in Figures 2 and 3. The PCR amplification product was recovered according to the instructions of the gel cleaning kit to obtain the PCR amplification product.
将PCR扩增产物(目的基因)与pMD19-T载体在16℃金属浴中连接12h,得到连接产物。连接体系如表4所示。The PCR amplification product (target gene) was connected to the pMD19-T vector in a 16°C metal bath for 12 hours to obtain a connection product. The connection system is shown in Table 4.
表4为连接体系Table 4 shows the connection system
将连接产物转化至大肠杆菌BL 21感受态细胞中,并涂于氨苄板上,于37℃培养12~16h后,挑取单菌落置于含有氨苄的LB(Luria-Bertani)液体培养基中,得到菌液,将该菌液置于37℃摇床培养过夜,按质粒提取试剂盒的说明书提取菌液中的质粒,将鉴定为阳性的质粒进行测序,使用DNAMAN软件与参考序列比对分析。结果如图4和图5所示,由图4可知,Hc-NIM1基因与GenBank基因库中公布的基因AM040235相似度为99.79%,由图5可知,Hc-ES15基因与GenBank基因库中公布的基因MT408359相似度为99.74%,阳性质粒为pMD19-T-NIM1和pMD19-T-ES15。The ligation product was transformed into Escherichia coli BL 21 competent cells and applied to ampicillin plates. After culturing at 37°C for 12 to 16 hours, a single colony was picked and placed in LB (Luria-Bertani) liquid medium containing ampicillin to obtain a bacterial solution, which was placed in a 37°C shaker for overnight culture. The plasmid in the bacterial solution was extracted according to the instructions of the plasmid extraction kit, and the positive plasmid was sequenced and compared with the reference sequence using DNAMAN software. The results are shown in Figures 4 and 5. As shown in Figure 4, the similarity between the Hc-NIM1 gene and the gene AM040235 published in the GenBank gene library is 99.79%, and as shown in Figure 5, the similarity between the Hc-ES15 gene and the gene MT408359 published in the GenBank gene library is 99.74%. The positive plasmids are pMD19-T-NIM1 and pMD19-T-ES15.
将上述阳性质粒pMD19-T-NIM1和pMD19-T-ES15分别与克隆载体pET-32a于37℃水浴中酶切1.5h,得到酶切产物,酶切体系如表5所示。The above positive plasmids pMD19-T-NIM1 and pMD19-T-ES15 were respectively digested with the cloning vector pET-32a in a 37°C water bath for 1.5 h to obtain digestion products. The digestion system is shown in Table 5.
表5为重组克隆载体和表达载体双酶切体系Table 5 shows the double restriction enzyme digestion system of recombinant cloning vector and expression vector
将酶切产物利用浓度为1%的琼脂糖凝胶进行电泳,并用凝胶清洁回收试剂盒回收产物,分别得到目的片段酶切回收产物和pET-32a酶切回收产物,具体操作按凝胶清洁回收试剂盒的说明书进行。The digestion products were subjected to electrophoresis using 1% agarose gel, and the products were recovered using a gel cleaning recovery kit to obtain target fragment digestion recovery products and pET-32a digestion recovery products, respectively. The specific operations were performed according to the instructions of the gel cleaning recovery kit.
将目的片段酶切回收产物和pET-32a酶切回收产物在16℃连接仪中连接12h,得到连接产物,其中,连接体系如表6所示。The target fragment digestion recovery product and the pET-32a digestion recovery product were connected in a 16°C connector for 12 hours to obtain a connection product, wherein the connection system is shown in Table 6.
表6为目的片段与表达载体片段连接反应体系Table 6 is the target fragment and expression vector fragment ligation reaction system
将连接产物转入BL21感受态中,经涂板后过夜培养,再经过挑菌和摇菌提质粒,最后进行双酶切鉴定,鉴定时仍可采用表5提供的酶切体系。The ligation product was transferred into BL21 competent cells, cultured overnight after plating, and then the plasmid was extracted by picking and shaking the bacteria, and finally double enzyme digestion identification was performed. The enzyme digestion system provided in Table 5 can still be used for identification.
取阳性质粒制备的菌液5mL,转入300mL LB液体培养基中,于37℃摇床培养3~4h后,当菌液的OD值达到0.6时,按照体积比1:1000加入1MIPTG(Isopropylβ-D-Thiogalactoside,异丙基硫代半乳糖苷)诱导剂,于37℃摇床诱导表达8h。收集菌体,将菌体用10mL咪唑PBS缓冲液重悬该菌体,重悬后于冰浴超声离心,得到上清液。将该上清液经0.22μm滤器过滤后,缓慢流过His Tag亲和层析柱,流速控制在1mL/min;分别用10mM、20mM、40mM、60mM和250mM的咪唑洗脱液洗柱子,收集洗脱液,洗脱液通过SDS-PAGE分析图可知在咪唑浓度为250mM时洗脱蛋白浓度最高,如图6a和图6b所示,目的蛋白大小分别为36kD和34kD。Take 5 mL of bacterial solution prepared from the positive plasmid and transfer it into 300 mL of LB liquid medium. After culturing at 37°C for 3-4 hours, when the OD value of the bacterial solution reaches 0.6, add 1 MIPTG (Isopropylβ-D-Thiogalactoside) inducer at a volume ratio of 1:1000, and induce expression at 37°C for 8 hours. Collect the bacterial cells, resuspend the bacterial cells with 10 mL of imidazole PBS buffer, and then centrifuge them in an ice bath for ultrasonication to obtain the supernatant. The supernatant was filtered through a 0.22 μm filter and then slowly passed through a His Tag affinity chromatography column at a flow rate of 1 mL/min. The column was washed with 10 mM, 20 mM, 40 mM, 60 mM and 250 mM imidazole eluents, respectively, and the eluents were collected. The SDS-PAGE analysis of the eluent showed that the eluted protein concentration was the highest when the imidazole concentration was 250 mM, as shown in Figures 6a and 6b. The sizes of the target proteins were 36 kD and 34 kD, respectively.
将4μL重组Hc-NIM1蛋白、4μL重组Hc-ES15蛋白和16μL 5×SDS(十二烷基硫酸钠)混匀,在沸水中煮10min,置于冰上冷却,完成制样。用捻转血矛线虫成虫期羊血清和捻转血矛线虫L4期羊血清分别作为一抗,HRP标记的兔抗羊IgG为二抗,同时,将不同感染时期绵羊阳性血清作为对照组,分别进行Western blot(蛋白质印迹法)鉴定,结果如图7a~图7c所示,由图7a~图7c可知,成虫期羊血清和捻转血矛线虫L4期羊血清都能检测到目的条带。由此可证明成虫期和L4期幼虫的羊血清中含有识别Hc-NIM1和Hc-ES15的抗体。4 μL recombinant Hc-NIM1 protein, 4 μL recombinant Hc-ES15 protein and 16 μL 5×SDS (sodium dodecyl sulfate) were mixed, boiled in boiling water for 10 min, and placed on ice to cool to complete sample preparation. The sheep serum of the adult stage of Haemonchus twister and the sheep serum of the L4 stage of Haemonchus twister were used as primary antibodies, and the HRP-labeled rabbit anti-sheep IgG was used as the secondary antibody. At the same time, the positive serum of sheep at different infection periods was used as the control group, and Western blot (protein blotting) was performed for identification. The results are shown in Figures 7a to 7c. As shown in Figures 7a to 7c, the target bands can be detected in the sheep serum of the adult stage and the sheep serum of the L4 stage of Haemonchus twister. This proves that the sheep serum of the adult stage and the L4 stage larvae contain antibodies that recognize Hc-NIM1 and Hc-ES15.
鼠抗重组Hc-NIM1、Hc-ES15蛋白多克隆抗体的制备Preparation of mouse polyclonal antibodies against recombinant Hc-NIM1 and Hc-ES15 proteins
将重组Hc-NIM1蛋白、重组Hc-ES15蛋白分别与弗氏完全佐剂以体积比1:1混合乳化,在小鼠皮下分点注射,剂量为100μg蛋白/只;两周后二免,乳化剂用弗氏不完全佐剂,免疫剂量分别为50μg蛋白/只;一周后三免,剂量同二免;一周后尾部采血,分离血清,进行ELISA(酶联免疫吸附试验)效价测定,两组小鼠效价最高都可达到1:8192000。收集血清保存于-80℃。Recombinant Hc-NIM1 protein and recombinant Hc-ES15 protein were mixed with Freund's complete adjuvant at a volume ratio of 1:1 and emulsified, and injected subcutaneously at points in mice, with a dose of 100 μg protein/mouse; two weeks later, the second immunization was performed, and Freund's incomplete adjuvant was used as the emulsifier, and the immunization dose was 50 μg protein/mouse; one week later, the third immunization was performed, and the dose was the same as the second immunization; one week later, blood was collected from the tail, serum was separated, and ELISA (enzyme-linked immunosorbent assay) titer was determined, and the highest titer of both groups of mice could reach 1:8192000. The collected serum was stored at -80℃.
测量血清体积,加入乙酸缓冲液(0.06M、pH=4.6),血清与乙酸缓冲液的体积比为1:3;在磁力搅拌下,逐滴加入正辛酸(500mL血清/17mL正辛酸),搅拌30分钟;离心后收集上清液,用滤纸或双层纱布进行过滤;将过滤后的上清液装入透析袋中于0.01M PB(pH=7.4)溶液中进行透析,换水3次,于4℃过夜;取出透析袋,量取血清+PBS的体积,逐滴加入等体积的硫酸铵(由饱和硫酸铵溶液调pH值至7.0~7.2),离心后弃上清,得到沉淀,将沉淀用0.01MPB进行重悬,并于0.01M PB中透析后离心,收集上清液。Measure the volume of serum, add acetate buffer (0.06M, pH=4.6), and the volume ratio of serum to acetate buffer is 1:3; under magnetic stirring, add octanoic acid (500mL serum/17mL octanoic acid) dropwise, and stir for 30 minutes; collect the supernatant after centrifugation and filter with filter paper or double-layer gauze; put the filtered supernatant into a dialysis bag and dialyze in 0.01M PB (pH=7.4) solution, change the water 3 times, and keep at 4°C overnight; take out the dialysis bag, measure the volume of serum+PBS, add an equal volume of ammonium sulfate (adjust the pH value to 7.0-7.2 with a saturated ammonium sulfate solution) dropwise, discard the supernatant after centrifugation, and obtain a precipitate, resuspend the precipitate with 0.01MPB, dialyze in 0.01M PB, and centrifuge after collecting the supernatant.
用适量结合Buffer(Binding buffer)稀释该上清液,加入装有Protein G的琼脂糖纯化树脂的层析柱中,在4℃中平衡12h;调节阀门使液体以1mL/min的速度流出,用30mL洗杂Buffer洗柱,用15mL洗脱Buffer洗脱目的蛋白,收集洗脱液。可使用BCA蛋白浓度试剂盒(上海通蔚生物科技有限公司)测量蛋白浓度,在本实施例中,两种多克隆抗体的浓度均为2mg/mL。将纯化后的多克隆抗体分装保存于-80℃。Dilute the supernatant with an appropriate amount of Binding Buffer, add it to a chromatography column filled with agarose purification resin containing Protein G, and equilibrate it at 4°C for 12 hours; adjust the valve to allow the liquid to flow out at a rate of 1 mL/min, wash the column with 30 mL of Wash Buffer, elute the target protein with 15 mL of Elution Buffer, and collect the eluate. The protein concentration can be measured using a BCA protein concentration kit (Shanghai Tongwei Biotechnology Co., Ltd.). In this example, the concentration of both polyclonal antibodies is 2 mg/mL. The purified polyclonal antibodies are stored in aliquots at -80°C.
免疫层析胶体金试纸条的制备Preparation of immunochromatographic colloidal gold test strips
在洗干净的锥形瓶中加入500mL超纯水,置于可加热的磁力搅拌机上,煮至沸腾;称量0.1125g柠檬酸钠,溶解至3mL沸水中,得到柠檬酸钠溶液;向锥形瓶中加入5mL浓度为1%的氯金酸;将柠檬酸钠溶液快速加入锥形瓶,反应5~10min,得到胶体金溶液;可将胶体金溶液保存于4℃中备用。Add 500 mL of ultrapure water to a clean conical flask, place it on a heatable magnetic stirrer, and boil it; weigh 0.1125 g of sodium citrate, dissolve it in 3 mL of boiling water to obtain a sodium citrate solution; add 5 mL of 1% chloroauric acid to the conical flask; quickly add the sodium citrate solution to the conical flask, react for 5 to 10 minutes, and obtain a colloidal gold solution; the colloidal gold solution can be stored at 4°C for later use.
准备8个离心管,每管中加入1mL胶体金溶液,再分别加入0μL、1μL、2μL、3μL、4μL、5μL、6μL和7μL 0.2M K2CO3,混匀;每管加入30μg重组Hc-NIM1蛋白,混匀;每管加入100μL浓度为10%的NaCl溶液,混匀,观察胶体金溶液颜色变化,具体如图8a所示。通过肉眼观察胶体金溶液颜色变化可知,当加入2μL K2CO3时,rHc-NIM1组溶液颜色不再变化。实际标记时取颜色稳定管的后一管,即第4管,用pH试纸测定该管溶液的pH为6.5,可知标记重组Hc-NIM1蛋白的最佳pH值为6.5。Prepare 8 centrifuge tubes, add 1mL colloidal gold solution to each tube, then add 0μL, 1μL, 2μL, 3μL, 4μL, 5μL, 6μL and 7μL 0.2MK 2 CO 3 respectively, mix well; add 30μg recombinant Hc-NIM1 protein to each tube, mix well; add 100μL 10% NaCl solution to each tube, mix well, and observe the color change of the colloidal gold solution, as shown in Figure 8a. By observing the color change of the colloidal gold solution with the naked eye, it can be seen that when 2μL K 2 CO 3 is added, the color of the rHc-NIM1 group solution no longer changes. In actual labeling, take the last tube of the color stable tube, that is, the fourth tube, and use pH test paper to measure the pH of the solution in this tube to be 6.5, which shows that the optimal pH value for labeling recombinant Hc-NIM1 protein is 6.5.
准备8个离心管,每管加入1mL胶体金溶液,再分别加入0μL、1μL、2μL、3μL、4μL、5μL、6μL和7μL 0.2M K2CO3,混匀;每管加入30μg重组Hc-ES15蛋白,混匀;每管加入100μL浓度为10%的NaCl溶液,混匀,观察胶体金溶液颜色变化,具体如图8b所示。通过肉眼观察胶体金溶液颜色变化可知,当加入5μL K2CO3时,rHc-ES15组溶液颜色趋于稳定不再变化,实际标记时取颜色稳定管的后一管,即第7管,用pH试纸测定该管溶液的pH为8.5,可知标记重组Hc-ES15蛋白的最佳pH值为8.5。Prepare 8 centrifuge tubes, add 1mL colloidal gold solution to each tube, then add 0μL, 1μL, 2μL, 3μL, 4μL, 5μL, 6μL and 7μL 0.2MK 2 CO 3 respectively, mix well; add 30μg recombinant Hc-ES15 protein to each tube, mix well; add 100μL 10% NaCl solution to each tube, mix well, and observe the color change of the colloidal gold solution, as shown in Figure 8b. By observing the color change of the colloidal gold solution with the naked eye, it can be seen that when 5μL K 2 CO 3 is added, the color of the rHc-ES15 group solution tends to be stable and no longer changes. When actually marking, take the last tube of the color-stable tube, that is, the 7th tube, and use pH test paper to measure the pH of the solution in this tube to be 8.5. It can be seen that the optimal pH value for marking the recombinant Hc-ES15 protein is 8.5.
准备8个离心管,每管分别加入1mL胶体金溶液,用0.2M K2CO3调节胶体金溶液至最佳pH;分别加入0μg、2μg、4μg、6μg、8μg、10μg、12μg和14μg重组Hc-NIM1蛋白,混匀,静置30min;每管各加入100μL浓度为10%的NaCl溶液,混匀,静置30min;观察胶体金溶液颜色变化。结果如图9a所示,当加入8μg/mL重组Hc-NIM1蛋白时胶体金溶液不再变色,说明重组Hc-NIM1蛋白的最低标记量为8μg/mL。一般在实际应用中,都会多加10%~20%的蛋白量,因此重组Hc-NIM1蛋白的最佳标记量分别为10μg/mL。Prepare 8 centrifuge tubes, add 1mL colloidal gold solution to each tube, adjust the colloidal gold solution to the optimal pH with 0.2MK 2 CO 3 ; add 0μg, 2μg, 4μg, 6μg, 8μg, 10μg, 12μg and 14μg recombinant Hc-NIM1 protein, mix well, and let stand for 30min; add 100μL of 10% NaCl solution to each tube, mix well, and let stand for 30min; observe the color change of the colloidal gold solution. The result is shown in Figure 9a. When 8μg/mL recombinant Hc-NIM1 protein is added, the colloidal gold solution no longer changes color, indicating that the minimum labeling amount of recombinant Hc-NIM1 protein is 8μg/mL. Generally, in practical applications, 10% to 20% more protein is added, so the optimal labeling amount of recombinant Hc-NIM1 protein is 10μg/mL.
准备8个离心管,每管分别加入1mL胶体金溶液,用0.2M K2CO3调节胶体金溶液至最佳pH;分别加入0μg、2μg、4μg、6μg、8μg、10μg、12μg和14μg重组Hc-ES15蛋白,混匀,静置30min;每管各加入100μL浓度为10%的NaCl溶液,混匀,静置30min;观察胶体金溶液颜色变化。结果如图9b所示,当加入4μg/mL重组Hc-ES15蛋白时,胶体金溶液不再变色,说明重组Hc-ES15蛋白的最低标记量分别为4μg/mL。一般在实际应用中,都会多加10%~20%的蛋白量,因此重组Hc-ES15蛋白的最佳标记量分别为6μg/mL。Prepare 8 centrifuge tubes, add 1mL colloidal gold solution to each tube, adjust the colloidal gold solution to the optimal pH with 0.2MK 2 CO 3 ; add 0μg, 2μg, 4μg, 6μg, 8μg, 10μg, 12μg and 14μg recombinant Hc-ES15 protein, mix well, and let stand for 30min; add 100μL of 10% NaCl solution to each tube, mix well, and let stand for 30min; observe the color change of the colloidal gold solution. The results are shown in Figure 9b. When 4μg/mL recombinant Hc-ES15 protein is added, the colloidal gold solution no longer changes color, indicating that the minimum labeling amount of recombinant Hc-ES15 protein is 4μg/mL. Generally, in practical applications, 10% to 20% more protein is added, so the optimal labeling amount of recombinant Hc-ES15 protein is 6μg/mL.
制备金标垫Preparation of gold label pad
取规格为15mL的离心管,加入10mL胶体金溶液,加入适量0.2MK2CO3调节pH值至6.5,加入纯化的重组Hc-NIM1蛋白使其终浓度为10μg/mL,混匀后静置30min,加入1mL浓度为10%的BSA溶液,混匀,静置1h;于4℃环境下13000rpm离心30min,弃去上清,得到沉淀,将沉淀用500μL金标稀释液重悬该沉淀,得到金标抗原溶液,用喷金仪将该金标抗原溶液以6.0μL/cm的剂量喷在金标垫上,并置于37℃干燥。Take a centrifuge tube with a specification of 15 mL, add 10 mL of colloidal gold solution, add an appropriate amount of 0.2M K 2 CO 3 to adjust the pH value to 6.5, add purified recombinant Hc-NIM1 protein to make its final concentration 10 μg/mL, mix well and let it stand for 30 minutes, add 1 mL of 10% BSA solution, mix well, and let it stand for 1 hour; centrifuge at 13000 rpm for 30 minutes at 4°C, discard the supernatant to obtain a precipitate, resuspend the precipitate with 500 μL of gold label diluent to obtain a gold label antigen solution, spray the gold label antigen solution on the gold label pad at a dose of 6.0 μL/cm using a gold spray instrument, and place it at 37°C to dry.
取规格为15mL的离心管,加入10mL胶体金溶液,加入适量0.2MK2CO3调节pH值至8.5,加入纯化的重组Hc-ES15蛋白至其终浓度为6μg/mL,混匀后静置30min,加入1mL浓度为10% BSA溶液,混匀,静置1h;于4℃环境下13000rpm离心30min,弃去上清,得到沉淀,将沉淀用500μL金标稀释液重悬该沉淀,得到金标抗原溶液,用喷金仪将该金标抗原溶液以6.0μL/cm的剂量喷在金标垫上,并置于37℃干燥。Take a centrifuge tube with a specification of 15mL, add 10mL of colloidal gold solution, add appropriate amount of 0.2MK 2 CO 3 to adjust the pH value to 8.5, add purified recombinant Hc-ES15 protein to its final concentration of 6μg/mL, mix well and let stand for 30min, add 1mL of 10% BSA solution, mix well, let stand for 1h; centrifuge at 13000rpm for 30min at 4℃, discard the supernatant to obtain a precipitate, resuspend the precipitate with 500μL of gold label diluent to obtain a gold label antigen solution, spray the gold label antigen solution on the gold label pad at a dose of 6.0μL/cm with a gold spray instrument, and place it at 37℃ to dry.
按以下配方配制样品垫处理液:Na2HPO4·12H2O 2.87g,KH2PO4 0.73g,Tween-20(吐温-20)0.5mL,去离子水0.4L,充分溶解后定容至0.5L,pH值调至7.4。将样品垫浸泡在样品垫处理液中2h后,置于37℃干燥。Prepare the sample pad treatment solution according to the following formula: Na 2 HPO 4 ·12H 2 O 2.87 g, KH 2 PO 4 0.73 g, Tween-20 0.5 mL, deionized water 0.4 L, dilute to 0.5 L after fully dissolving, and adjust the pH value to 7.4. Soak the sample pad in the sample pad treatment solution for 2 h and place it at 37°C to dry.
C质控线包被浓度的优化:将纯化的鼠抗Hc-ES15蛋白多克隆抗体分别稀释至1.0mg/mL、1.5mg/mL、2.0mg/mL、2.5mg/mL和3.0mg/mL,喷至硝酸纤维素(NC)膜上,置于37℃烘干,滴加阴性血清,观察C质控线颜色深浅。结果如图10所示,由图10可知,C质控线包被多抗的最佳浓度为2.5mg/mL。Optimization of the coating concentration of the C quality control line: The purified mouse anti-Hc-ES15 protein polyclonal antibody was diluted to 1.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 2.5 mg/mL and 3.0 mg/mL, respectively, sprayed onto the nitrocellulose (NC) membrane, placed at 37°C for drying, and negative serum was added to observe the color depth of the C quality control line. The results are shown in Figure 10, from which it can be seen that the optimal concentration of the C quality control line coated polyclonal antibody is 2.5 mg/mL.
重组Hc-NIM1蛋白包被的T1检测线、重组Hc-ES15蛋白包被的T2检测线浓度的优化:将重组Hc-NIM1蛋白和重组Hc-ES15蛋白分别稀释至1.0mg/mL、2.0mg/mL、3.0mg/mL、4.0mg/mL和5.0mg/mL,喷至NC膜上,置于37℃烘干,滴加阳性血清,观察T1检测线和T2检测线颜色深浅。结果如图11a~图11c所示,T1检测线包被蛋白和T2检测线包被蛋白的最佳浓度均为2.0mg/mL。Optimization of the concentration of the T1 test line coated with recombinant Hc-NIM1 protein and the T2 test line coated with recombinant Hc-ES15 protein: The recombinant Hc-NIM1 protein and the recombinant Hc-ES15 protein were diluted to 1.0 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 4.0 mg/mL and 5.0 mg/mL, respectively, sprayed onto the NC membrane, dried at 37°C, and positive serum was added to observe the color depth of the T1 test line and the T2 test line. The results are shown in Figures 11a to 11c. The optimal concentrations of the T1 test line coating protein and the T2 test line coating protein are both 2.0 mg/mL.
胶体金试纸条的组装:将NC膜、金标垫、样品垫和吸水垫依次粘贴到PVC板上,得到结构如图1所示的胶体金试纸条,用切条机裁成宽为4mm的长条,保存于铝箔袋内备用。Assembly of colloidal gold test strips: NC film, gold label pad, sample pad and absorbent pad were sequentially pasted onto the PVC board to obtain a colloidal gold test strip with a structure as shown in FIG1 . The strips were cut into strips with a width of 4 mm using a strip cutter and stored in an aluminum foil bag for later use.
胶体金试纸条使用及判定:取少量绵羊阳性血清及阴性血清,以pH值为7.4、0.1MPB溶液按照体积5倍进行稀释,得到稀释血清,取20μL稀释血清作为样本进行检测。将稀释血清滴到样品垫上,室温下作用5~10min。Use and determination of colloidal gold test strips: Take a small amount of sheep positive serum and negative serum, dilute them 5 times by volume with pH 7.4, 0.1MPB solution to obtain diluted serum, and take 20μL of diluted serum as a sample for testing. Drop the diluted serum on the sample pad and let it act at room temperature for 5 to 10 minutes.
如图12a所示,阴性结果判断:T1检测线和T2检测线均不出现红色条带,C质控线呈现红色条带,这说明样本中没有捻转血矛线虫抗体。As shown in Figure 12a, negative result judgment: no red bands appear on the T1 test line and the T2 test line, and a red band appears on the C quality control line, which indicates that there is no Haemonchus contortus antibody in the sample.
如图12b所示,阳性结果判断:C质控线和任一条检测线(T1检测线或T2检测线)呈现红色条带,这说明样本中存在捻转血矛线虫抗体。As shown in FIG12 b , a positive result is judged as follows: the C quality control line and any one of the test lines (T1 test line or T2 test line) present red stripes, which indicates that antibodies to Haemonchus contortus are present in the sample.
如图12c所示,如果T1检测线、T2检测线和C质控线均不出现红色条带或仅有检测线出现红色条带,则说明该胶体金试纸条失效。As shown in FIG12c , if no red strip appears on the T1 test line, the T2 test line, and the C quality control line, or only the test line appears a red strip, it indicates that the colloidal gold test strip is invalid.
胶体金试纸条性能的检测Testing of the performance of colloidal gold test strips
ES15和NIM1之间的交叉反应验证:将纯化后的鼠抗Hc-NIM1蛋白多克隆抗体以2.5mg/mL的浓度包被C质控线,将重组Hc-NIM1蛋白以2.0mg/mL的浓度包被T1检测线,与喷有金标Hc-NIM1的金标垫进行组装;将纯化后的鼠抗Hc-ES15蛋白多克隆抗体以2.5mg/mL的浓度包被C质控线,重组Hc-ES15蛋白以2.0mg/mL的浓度包被T2检测线,与喷有金标Hc-ES15的金标垫进行组装。分别滴加捻转血矛线虫阳性血清于样品垫上,检测ES15和NIM1与彼此的多克隆抗体是否存在交叉反应。经检验,如图13所示,ES15、NIM与彼此的多克隆抗体无交叉反应,图13中,右一为阴性对照。Verification of cross-reaction between ES15 and NIM1: The purified mouse anti-Hc-NIM1 protein polyclonal antibody was coated on the C quality control line at a concentration of 2.5 mg/mL, and the recombinant Hc-NIM1 protein was coated on the T1 detection line at a concentration of 2.0 mg/mL, and assembled with the gold-labeled pad sprayed with gold-labeled Hc-NIM1; the purified mouse anti-Hc-ES15 protein polyclonal antibody was coated on the C quality control line at a concentration of 2.5 mg/mL, and the recombinant Hc-ES15 protein was coated on the T2 detection line at a concentration of 2.0 mg/mL, and assembled with the gold-labeled pad sprayed with gold-labeled Hc-ES15. The positive serum of Haemonchus twistingensis was dripped on the sample pad respectively to detect whether ES15 and NIM1 had cross-reaction with each other's polyclonal antibodies. After inspection, as shown in Figure 13, ES15 and NIM had no cross-reaction with each other's polyclonal antibodies. In Figure 13, the first on the right is a negative control.
特异性检测:将羊捻转血矛线虫、羊细粒棘球蚴、羊球虫、羊肝片吸虫和牛片形吸虫阳性血清均稀释5倍后取20μL用制备的胶体金试纸条检测,10min内判定结果。结果如图14所示,由图14可知,只有滴加羊捻转血矛线虫阳性血清的胶体金试纸条的T线才会显色。Specific detection: After the positive serum of sheep Haemonchus contortus, sheep Echinococcus granulosus, sheep coccidia, sheep Fasciola hepatica and cattle Fasciola calyx was diluted 5 times, 20 μL was taken and tested with the prepared colloidal gold test strip, and the result was determined within 10 minutes. The result is shown in Figure 14. As can be seen from Figure 14, only the T line of the colloidal gold test strip with the positive serum of sheep Haemonchus contortus added will show color.
敏感性检测:将捻转血矛线虫阳性血清分别以1∶1、1∶5、1∶10、1∶20、1∶40和1∶80的比例进行稀释,吸取20μL稀释后的血清用胶体金试纸条检测,10min内判定结果。结果如图15所示,由图15可知,阳性血清的最低检测效价为1∶40。Sensitivity test: The positive serum of Haemonchus contortus was diluted at a ratio of 1:1, 1:5, 1:10, 1:20, 1:40 and 1:80, and 20 μL of the diluted serum was tested with colloidal gold test strips, and the result was determined within 10 minutes. The results are shown in FIG15 , from which it can be seen that the minimum detection titer of the positive serum is 1:40.
重复性检测:以相同的条件重复制备三批胶体金试纸条,用阳性血清和阴性血清分别检测胶体金试纸条的批间重复性,结果如图16a~图16c所示,由图16a~图16c可知,该胶体金试纸条的批间重复性良好。Repeatability test: Three batches of colloidal gold test strips were prepared repeatedly under the same conditions, and the batch repeatability of the colloidal gold test strips was tested with positive serum and negative serum, respectively. The results are shown in Figures 16a to 16c. It can be seen from Figures 16a to 16c that the batch repeatability of the colloidal gold test strips is good.
稳定性检测:将胶体金试纸条分别置于4℃下保存30天、60天和90天后,用胶体金试纸条检测,结果如图17a~图17c所示,由图17a~图17c可知,在稳定的条件下,该胶体金试纸条能在4℃下保存90天仍有效。Stability test: The colloidal gold test strips were stored at 4°C for 30 days, 60 days and 90 days, respectively, and then tested with the colloidal gold test strips. The results are shown in Figures 17a to 17c. It can be seen from Figures 17a to 17c that under stable conditions, the colloidal gold test strips can be stored at 4°C for 90 days and still be effective.
确定感染天数的灵敏性:分别收集捻转血矛线虫感染湖羊后第5、7、9、11、13、15、20、25、30、40、60、90、120和125天的血清,稀释5倍数后滴加于该胶体金试纸条的加样区,观察T线的颜色变化。结果如图18a和图18b所示,由图18a和图18b可知,制备的胶体金试纸条最早能在捻转血矛线虫感染后第7天检出,感染后第120天仍能检出抗体。Sensitivity of determining the number of days of infection: The serum of Hu sheep infected with Haemonchus contortus was collected on the 5th, 7th, 9th, 11th, 13th, 15th, 20th, 25th, 30th, 40th, 60th, 90th, 120th and 125th days respectively, and was diluted 5 times before being dripped into the sample application area of the colloidal gold test strip to observe the color change of the T line. The results are shown in Figures 18a and 18b. As can be seen from Figures 18a and 18b, the prepared colloidal gold test strip can detect Haemonchus contortus infection as early as the 7th day, and antibodies can still be detected on the 120th day after infection.
诊断方法的临床应用Clinical application of diagnostic methods
采集114头湖羊的血清样本以及对应的粪便样本,将血清样本进行胶体金试纸条检测,将粪便样本进行粪便虫卵检测,并比较两种诊断方法。结果如表7所示,由表7可知,粪便虫卵检测出阳性样本20份,阳性率为17.54%(20/114);胶体金试纸条检测技术检出阳性样品27份,阳性率为23.68%(27/114),粪便虫卵检测法的符合率为93.86%(107/114)。Serum samples and corresponding fecal samples were collected from 114 Hu sheep, and the serum samples were tested by colloidal gold test strips, and the fecal samples were tested for fecal ova, and the two diagnostic methods were compared. The results are shown in Table 7. As can be seen from Table 7, 20 positive samples were detected by fecal ova, with a positive rate of 17.54% (20/114); 27 positive samples were detected by colloidal gold test strips, with a positive rate of 23.68% (27/114), and the fecal ova detection method had a compliance rate of 93.86% (107/114).
表7为胶体金检测技术与粪检结果对比Table 7 is a comparison of colloidal gold detection technology and fecal examination results
由表7可知,相比于粪便虫卵检测,本实施例提供的胶体金试纸条检测的阳性率更高,能够更好地在临床应用。It can be seen from Table 7 that, compared with fecal ova detection, the colloidal gold test strip provided in this embodiment has a higher positive rate and can be better used in clinical applications.
本发明提供了一种检测捻转血矛线虫的双重胶体金试纸条及其制备方法,该双重胶体金试纸条能够适用于捻转血矛线虫感染的快速、简便和廉价的诊断。利用重组Hc-NIM1蛋白和重组Hc-ES15蛋白分别包被的两条检测线,使得本发明实施例提供的双重胶体金试纸条具有良好的敏感性,同时,筛选捻转血矛线虫在L4期和成虫期表达量较高的蛋白作为诊断抗原,在感染后7天至120天均能做出准确诊断,适用于感染期各个阶段的检测。本发明实施例提供的双重胶体金试纸条操作简单,检测快速,有助于一线基层快速、准确的掌握湖羊捻转血矛线虫病的流行发展,在反刍动物捻转血矛线虫病的防控中具有较好的应用前景。The present invention provides a double colloidal gold test strip for detecting Haemonchus twister and a preparation method thereof, and the double colloidal gold test strip can be applied to the rapid, simple and inexpensive diagnosis of Haemonchus twister infection. The double colloidal gold test strip provided by the embodiment of the present invention has good sensitivity by using two detection lines respectively coated with recombinant Hc-NIM1 protein and recombinant Hc-ES15 protein. At the same time, the protein with high expression level of Haemonchus twister in L4 stage and adult stage is screened as a diagnostic antigen, and an accurate diagnosis can be made from 7 days to 120 days after infection, which is suitable for detection at all stages of the infection period. The double colloidal gold test strip provided by the embodiment of the present invention is simple to operate and has fast detection, which helps the front-line grassroots to quickly and accurately grasp the prevalence and development of Haemonchus twister disease in Hu sheep, and has a good application prospect in the prevention and control of Haemonchus twister disease in ruminants.
虽然本发明所揭露的实施方式如上,但所述的内容仅为便于理解本发明而采用的实施方式,并非用以限定本发明。任何本发明所属领域内的技术人员,在不脱离本发明所揭露的精神和范围的前提下,可以在实施的形式及细节上进行任何的修改与变化,但本发明的专利保护范围,仍须以所附的权利要求书所界定的范围为准。Although the embodiments disclosed in the present invention are as above, the contents described are only embodiments adopted to facilitate understanding of the present invention and are not intended to limit the present invention. Any technician in the field to which the present invention belongs can make any modifications and changes in the form and details of implementation without departing from the spirit and scope disclosed in the present invention, but the patent protection scope of the present invention shall still be subject to the scope defined in the attached claims.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310862708.7A CN116840472A (en) | 2023-07-13 | 2023-07-13 | Double-colloidal gold test strip for detecting haemonchus contortus and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310862708.7A CN116840472A (en) | 2023-07-13 | 2023-07-13 | Double-colloidal gold test strip for detecting haemonchus contortus and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116840472A true CN116840472A (en) | 2023-10-03 |
Family
ID=88170499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310862708.7A Pending CN116840472A (en) | 2023-07-13 | 2023-07-13 | Double-colloidal gold test strip for detecting haemonchus contortus and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116840472A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN119899257A (en) * | 2025-04-02 | 2025-04-29 | 南京农业大学 | A parasite protein peptide with immune enhancement effect and its application |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113092753A (en) * | 2021-04-03 | 2021-07-09 | 中国农业科学院兰州兽医研究所 | Colloidal gold duplex detection test strip for antibody of African swine fever virus and preparation method thereof |
CN113640524A (en) * | 2021-08-02 | 2021-11-12 | 南京农业大学 | Composite antigen for detecting haemonchus contortus infection and application thereof |
CN113777312A (en) * | 2021-09-03 | 2021-12-10 | 普十生物科技(北京)有限公司 | Preparation method of hepatitis B antibody fragment, kit and application |
CN215728195U (en) * | 2021-07-12 | 2022-02-01 | 圣湘生物科技股份有限公司 | Novel coronavirus SARS-CoV-2 antibody detection test paper strip |
-
2023
- 2023-07-13 CN CN202310862708.7A patent/CN116840472A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113092753A (en) * | 2021-04-03 | 2021-07-09 | 中国农业科学院兰州兽医研究所 | Colloidal gold duplex detection test strip for antibody of African swine fever virus and preparation method thereof |
CN215728195U (en) * | 2021-07-12 | 2022-02-01 | 圣湘生物科技股份有限公司 | Novel coronavirus SARS-CoV-2 antibody detection test paper strip |
CN113640524A (en) * | 2021-08-02 | 2021-11-12 | 南京农业大学 | Composite antigen for detecting haemonchus contortus infection and application thereof |
CN113777312A (en) * | 2021-09-03 | 2021-12-10 | 普十生物科技(北京)有限公司 | Preparation method of hepatitis B antibody fragment, kit and application |
Non-Patent Citations (2)
Title |
---|
GELDHOF, P.等: "Characterisation of the two most abundant genes in the Haemonchus contortus expressed sequence tag dataset" * |
PRASANTH, V.等: "Genetic diversity in 15 kDa ES antigen of Haemonchus contortus", Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/nucleotide/MT408348.1?Report=genbank&log$=nuclto&blast_rank=2&RID=RP8U51F5013> * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN119899257A (en) * | 2025-04-02 | 2025-04-29 | 南京农业大学 | A parasite protein peptide with immune enhancement effect and its application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110105436B (en) | ELISA detection kit for porcine circovirus type 3 antibody and preparation method and application thereof | |
CN104007261B (en) | Fowl three kinds of breathing problem three quick detection kit and application | |
CN110146697B (en) | An immunoassay strip for rapid detection of P. falciparum, P. vivax, P. vivax and P. ovale | |
CN106432440B (en) | PPA-ELISA (polymerase chain reaction-enzyme linked immunosorbent assay) detection kit for Brucella melitensis antibody and preparation method of PPA-ELISA detection kit | |
BR112015008036B1 (en) | POPULATION OF ISOLATED PEPTIDES, METHOD TO DETECT AN ANTIBODY IN A SAMPLE, METHOD TO DIAGNOSE MONOCYTIC AND/OR GRANULOCYTIC EHRLICHIOSIS, METHOD TO DETECT THE PRESENCE OF ANTIBODIES AND KIT | |
CN110196323A (en) | A kind of detection African swine fever virus antigen fluorescent microsphere immune test paper card and preparation method and application | |
CN111537716B (en) | A diagnostic kit for early infection of Haemonchus contortus | |
CN116840472A (en) | Double-colloidal gold test strip for detecting haemonchus contortus and preparation method thereof | |
CN107365364A (en) | A kind of quick detection kit of Adenovirus Antigen preparation method and the detection adenovirus antibody prepared using the antigen | |
CN110642927A (en) | Application of protein in preparation of medicine for preventing cryptococcus pyogenes infection | |
CN113846115A (en) | Dermatophagoides pteronyssinus class I allergen pro-Der p1 recombinant protein and preparation method and application thereof | |
CN102183644A (en) | Indirect capripox antibody enzyme-linked immuno sorbent assay (ELISA) diagnostic kit and preparation method | |
CN103983780B (en) | Detect colloidal gold immuno-chromatography test paper strip and the preparation method of Pigeon paramyxovirus-I | |
CN112946294A (en) | Novel coronavirus 2019-nCoV antibody detection test strip and preparation method and application thereof | |
CN110540578A (en) | Preparation of a recombinant protein in the main antigenic epitope region of pseudorabies virus GE gene and colloidal gold immunochromatographic test strips | |
CN101012445A (en) | Colloidal gold immune chromatography fast differential diagnosis kit of chicken avian influenza vaccine immunity and virus strain infection and application | |
CN103197078B (en) | Application of salmonella pullorum secreted protein SpiC | |
CN110221060B (en) | Antigen for early diagnosis of haemonchus contortus infection and application thereof | |
CN101206224A (en) | A kind of immunochromatographic test paper for detecting ricin and its preparation method | |
CN1286971C (en) | Monoclonal antibody, testing kit including the monoclonal antibody and application | |
CN116589565A (en) | An African swine fever p72 monoclonal antibody and its application | |
JPH11346768A (en) | Antigenic protein of canine distemper virus nucleocapsid protein and anti-canine distemper virus nucleocapsid protein antibody | |
CN114034860A (en) | A kind of indirect ELISA detection method of Mycobacterium tuberculosis MTB39A protein antibody and its kit | |
CN103454418B (en) | A kind of Fasciola gigantica immune chromatography rapid detecting test paper strip and preparation method thereof | |
Dankaona et al. | Recombinant expression and characterization of Canine circovirus capsid protein for diagnosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |